Bloomberg
Gilead's Virus Drug Remdesivir Gains Approval From FDA
Oct.22 -- The U.S. Food and Drug Administration approved Gilead Sciences Inc.’s antiviral therapy remdesivir on Thursday, making it the first drug to obtain formal clearance for treating the coronavirus. Still, the drug hasn’t been...
Curated Video
President Trump Announces Emergency Authorization For Plasma Treatment
Many scientists and physicians believe that convalescent plasma might provide some benefit but it is far from a breakthrough.
Bloomberg
Johnson & Johnson Begins Study of One-Dose Covid Shot
Sep.23 -- Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot. Bloomberg's Robert Langreth reports on...
Curated Video
Concerns Raised About CDC Handling Of Virus Test Results
The agency is combining results from two different COVID-19 tests.
Bloomberg
Covid-19: Johns Hopkins Sees ‘Great Hope’ in Antibodies Research
May.01 -- Johns Hopkins Bloomberg School of Public Health Professor Andrew Pekosz discusses testing of existing medicines as coronavirus treatments, and the importance of antibody research and testing. He speaks on "Bloomberg...
Bloomberg
Antibody Tests Don’t Tell If Protected From Reinfection: Johns Hopkins
May.29 -- Johns Hopkins Bloomberg School of Public Health Professor Andrew Pekosz discusses antibody testing, and wearing masks as part of one step of protection against Covid-19. He speaks on "Bloomberg Surveillance." The Bloomberg...
Bloomberg
U.K. Mass Antibody Study Finds 3.4 Million Had Covid-19
Aug.13 -- Imperial College London Professor of Public Health Helen Ward explains the findings of a mass antibody survey of 100,000 U.K. residents that provides insight into the coronavirus pandemic in the nation. She speaks on "Bloomberg...
Bloomberg
Pfizer Plans to Request FDA Nod for Covid Booster
Jul.08 -- Pfizer Inc. plans to request U.S. emergency authorization for a third booster dose of its vaccine, Robert Langreth reports on "Bloomberg Daybreak: Australia."
Bloomberg
Will Vaccines Protect Us From All Covid-19 Variants?
Apr.19 -- Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed...
Curated Video
Early Data From Novavax COVID-19 Vaccine Shows Promise
It said test subjects — who received two doses of its vaccine — developed four times more antibodies than those who previously had COVID-19.
Curated Video
Doctors testing plasma as "immune therapy"
Doctors around the world are dusting off a century-old treatment for infections: Infusions of blood plasma teeming with immune molecules that helped survivors beat the new coronavirus.
Bloomberg
Reopening Needs a Different Kind of Covid-19 Monitoring: John’s Hopkins
May.15 -- Johns Hopkins Bloomberg School of Public Health Professor Andrew Pekosz discusses taking a different approach to Covid-19 testing and monitoring as economies begin to reopen. He speaks on "Bloomberg Surveillance." The Bloomberg...
Press Association
Sir Patrick Vallance: Britain set to avoid second deadly wave of coronavirus after lockdown
Though the UK has now passed Italy to record the highest death toll in Europe, Sir Patrick Vallance told MPs he was “optimistic”.
The chief scientific adviser explained: “I think if we do test, track and tracing well, and we keep the...
Curated Video
Doctors testing plasma as "immune therapy"
Doctors around the world are dusting off a century-old treatment for infections: Infusions of blood plasma teeming with immune molecules that helped survivors beat the new coronavirus.
Bloomberg
No Holy Grails in Covid-19 Treatments, Johns Hopkins’ Farley Says
Oct.29 -- Johns Hopkins University Professor of Nursing Jason Farley discusses what is being learned about the effects of Covid-19, patient response to antibody treatments, and the effectiveness of lockdowns in stopping the spread of...
Sky News
Drs Susan Hopkins and Jenny Harries speak during Downing Street press briefing
CLEAN: Interior shots of Dr Susan Hopkins and Dr Jenny Harries of Public Health England answering a question on herd immunity during the Downing Street coronavirus press briefing on 25 January 2021 in London, United Kingdom
Curated Video
COVID Variants Raise New Challenges For Health Care Workers
Health officials have documented more than 70 cases of COVID variants in 11 states.
Bloomberg
Mixing Covid-19 Vaccines Raises Antibodies, Study Finds
Mixing Covid vaccines produces as much or more antibodies as using the same shot as a booster, according to preliminary results of a widely awaited U.S. government-sponsored trial. Today, FDA advisers begin meeting to debate whether...
Curated Video
Study results suggest 2 Ebola drugs saving lives
Two Ebola patients who were treated with new drugs in the city of Goma in eastern Congo have been declared "cured" and returned to their home.
Curated Video
Immunologist: Virus not man-made, 2nd wave likely
A leading virus expert from France's world-renowned Pasteur Insitute said on Friday he was "convinced" the coronavirus was "not created by any manipulation."
Sky News
Chris Whitty and Patrick Vallance speaking at press conference
CLEAN: Interior shots of Sir Patrick Vallance, chief scientific advisor and Professor Chris Whitty, Chief Medical Officer, speaking at a press conference to discuss the rise in coronavirus cases in the UK on 21 September 2020 in London,...
Sky News
Boris Johnson visiting Oxford vaccine research lab
CLEAN: Interior shots of Prime Minister Boris Johnson on a visit to the Oxford coronavirus lab talking to scientists on 18 September 2020 in Oxford, United Kingdom
Bloomberg
Covid-19 Fight Needs More Antibody, Plasma Data: Johns Hopkins
Aug.20 -- Johns Hopkins University Professor of Nursing Jason Farley discusses information that is still needed in order to fight Covid-19. He speaks with Bloomberg’s Francine Lacqua on "Bloomberg Surveillance." The Bloomberg School of...
Curated Video
Many COVID-19 Survivors Are Losing Antibodies Quicker Than Expected
Some researchers worry this will impact the body's ability to fight off the virus a second time.